Investors evaluating the beverage alcohol sector frequently weigh a broad global brewer against a more domestically concentrated player. BUD and STZ both fall within consumer staples yet operate under very different models, which makes their relative performance and positioning useful for anyone assessing defensive holdings. This analysis matters most for those focused on steady cash-flow businesses, dividend strategies, or traders tracking momentum within the alcohol space. Reviewing recent price action, earnings trends, and risk factors side by side helps clarify which name may present the stronger risk-reward balance at present.
BUD, or Anheuser-Busch InBev, ranks among the world’s largest brewers, based in Leuven, Belgium, and listed on the New York Stock Exchange as an ADR. Its lineup covers mainstream, premium, and super-premium beers plus a growing Beyond Beer and no-alcohol category, with brands including Budweiser, Corona, and Michelob Ultra. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Recent results reflect a resilient earnings profile. In the latest full-year report, the company posted organic revenue growth of roughly 2%, a 4.4% rise in revenue per hectoliter, and underlying EPS of $3.73, up about 6% in dollar terms. Normalized EBITDA increased roughly 4.9%, with margin expansion of about 101 basis points. Free cash flow reached around $11.3 billion, the dividend rose 15%, and a multi-billion-dollar share repurchase program continued. Market-share gains occurred in about two-thirds of its markets, though softer consumer demand, unseasonal weather, and weaker volumes in China limited top-line gains.
STZ, or Constellation Brands, produces and imports beer, wine, and spirits. Its beer segment, centered on Mexican imports such as Modelo Especial, Corona Extra, and Pacifico, accounts for the bulk of revenue, while a smaller wine and spirits unit has undergone divestitures and restructuring.
STZ has followed a more volatile path recently. The stock hit a 52-week low near $110 in early October before rebounding in recent weeks on better quarterly results. In the most recent quarter, EPS rose roughly 25% year over year with a return to revenue growth, and a major bank upgraded the shares. These moves helped rebuild some confidence after earlier periods when management lowered guidance and withdrew longer-term targets. Even so, the stock sits well below its prior 52-week high amid concerns over declining U.S. alcohol consumption, softer demand in key demographics, and import-related cost pressures.
The companies differ most on geographic and category concentration. BUD operates across dozens of markets, which spreads the impact of any single regional slowdown and offers exposure to premiumization and no-alcohol growth worldwide. STZ remains heavily U.S.-centric, with revenue tied largely to imported Mexican beer, linking its results closely to domestic consumption trends and import economics.
On momentum, the picture is mixed. BUD has delivered steady profitability gains and shareholder returns, while STZ has posted a sharper rebound from lower levels. That recovery is positive but carries added uncertainty, partly because it starts from a depressed base and still contends with structural pressures such as falling per-capita alcohol consumption and tariff exposure on Mexican imports.
Risk factors also vary. BUD’s main challenges center on volume softness and currency moves, whereas STZ faces more structural issues including category decline and concentration. On valuation, STZ trades at a lower forward price-to-earnings multiple, reflecting the market’s discount for greater uncertainty, while BUD carries a premium tied to its diversification and more reliable cash generation.
Considering factors such as trend consistency, fundamental stability, and catalyst quality, Tickeron’s AI currently leans toward BUD in this comparison. BUD’s wider geographic reach, ongoing margin expansion, and durable free cash flow create a more stable trend profile, while STZ’s recent gains, though notable, remain linked to a recovery from lower levels amid ongoing industry headwinds. The AI view is probabilistic rather than absolute, indicating relatively higher confidence in BUD’s positioning under current conditions. Investors should keep monitoring both names as sentiment and fundamentals shift.
In my regular research, I often reference Tickeron’s AI Trading Bots to review how automated strategies are positioned across names like these. The platform provides performance data and strategy details that complement fundamental work, helping me gauge broader market dynamics without replacing core analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
The 10-day RSI Indicator for STZ moved out of overbought territory on November 06, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 instances where the indicator moved out of the overbought zone. In 16 of the 25 cases the stock moved lower in the days that followed. This puts the odds of a move down at 64%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where STZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.
STZ broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on October 07, 2026. You may want to consider a long position or call options on STZ as a result. In 50 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 53%.
The Moving Average Convergence Divergence (MACD) for STZ just turned positive on October 06, 2026. Looking at past instances where STZ's MACD turned positive, the stock continued to rise in 20 of 40 cases over the following month. The odds of a continued upward trend are 50%.
STZ moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for STZ crossed bullishly above the 50-day moving average on October 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 6 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 40%.
Following a +8.78% 3-day Advance, the price is estimated to grow further. Considering data from situations where STZ advanced for three days, in 152 of 300 cases, the price rose further within the following month. The odds of a continued upward trend are 51%.
The Aroon Indicator entered an Uptrend today. In 82 of 214 cases where STZ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 38%.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. STZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 42 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 64 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: STZ's P/B Ratio (2.937) is slightly higher than the industry average of (1.356). P/E Ratio (13.495) is within average values for comparable stocks, (-0.201). Projected Growth (PEG Ratio) (1.436) is also within normal values, averaging (2.082). Dividend Yield (0.029) settles around the average of (0.037) among similar stocks. P/S Ratio (2.366) is also within normal values, averaging (1.539).
The Tickeron PE Growth Rating for this company is 79 (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 70, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
an alcoholic beverages distributor
Industry FoodMeatFishDairy